<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" version="2.0">
  <channel>
    <title>NewsTin - Cancer Therapy</title>
    <link>http://www.newstin.com/us/cancer-therapy</link>
    <description>Global Social News Platform</description>
    <copyright>Copyright © 2006 I2S a.s.</copyright>
    <dc:rights>Copyright © 2006 I2S a.s.</dc:rights>
    <item>
      <title>Unfortunately A New Beginning</title>
      <link>http://www.newstin.com/tag/us/66466019</link>
      <description>In a couple of weeks I'll see the 3rd anniversary of my cancer surgery. I should be real happy to be alive and functional, but that takes a back seat to starting a new round of chemotherapy. In a way, I'm no better off than I...</description>
      <pubDate>Fri, 04 Jul 2008 07:46:44 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/66466019</guid>
      <dc:date>2008-07-04T07:46:44Z</dc:date>
    </item>
    <item>
      <title>Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in...</title>
      <link>http://www.newstin.com/tag/us/66456940</link>
      <description>Pre-Specified Primary Efficacy Endpoint Met in Stage 1 of Two-Stage Study - TUSTIN, Calif., July 2, 2008 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. today reported that its lead product candidate bavituximab...</description>
      <pubDate>Fri, 04 Jul 2008 10:16:00 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/66456940</guid>
      <dc:date>2008-07-04T10:16:00Z</dc:date>
    </item>
    <item>
      <title>Breast reconstruction can have lasting benefits</title>
      <link>http://www.newstin.com/tag/us/66505825</link>
      <description>NEW YORK (Reuters Health) - Breast reconstruction after cancer surgery can have lasting benefits for women's psychological well-being and body image, a new study suggests. Research has shown that for women who have a mastectomy...</description>
      <pubDate>Fri, 04 Jul 2008 14:20:22 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/66505825</guid>
      <dc:date>2008-07-04T14:20:22Z</dc:date>
    </item>
    <item>
      <title>Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised...</title>
      <link>http://www.newstin.com/tag/us/66401319</link>
      <description>Lancet Oncol. 2008 Jun 24; Thomas M, R_be C, Hoffknecht P, Macha HN, Freitag L, Linder A, Willich N, Hamm M, Sybrecht GW, Ukena D, Deppermann KM, Dröge C, Riesenbeck D, Heinecke A, Sauerland C, Junker K, Berdel WE, Semik M,</description>
      <pubDate>Fri, 04 Jul 2008 03:57:01 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/66401319</guid>
      <dc:date>2008-07-04T03:57:01Z</dc:date>
    </item>
    <item>
      <title>A Synthetic Lethal Therapeutic Approach: Poly(ADP) Ribose Polymerase Inhibitors for the Treatment...</title>
      <link>http://www.newstin.com/tag/us/66420344</link>
      <description>Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom. Cancer cells frequently harbor defects in DNA repair pathways, leading to genomic instability. This can foster tumorigenesis...</description>
      <pubDate>Fri, 04 Jul 2008 06:24:01 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/66420344</guid>
      <dc:date>2008-07-04T06:24:01Z</dc:date>
    </item>
    <item>
      <title>New plastic surgeon comes to town</title>
      <link>http://www.newstin.com/tag/us/66431845</link>
      <description>Staff Writer When Dr. Bruce Lattyak talks of plastic surgery, he sometimes sounds like a sculptor or an artist. Lattyak, 39, is a plastic surgeon who moved with his wife and two daughters to Grass Valley last month from...</description>
      <pubDate>Fri, 04 Jul 2008 07:00:00 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/66431845</guid>
      <dc:date>2008-07-04T07:00:00Z</dc:date>
    </item>
    <item>
      <title>3rd ESU Masterclass Presents Insightful Updates On Urological Oncology</title>
      <link>http://www.newstin.com/tag/us/66470150</link>
      <description>Insightful updates on onco-urological issues were the focus of the 3rd ESU masterclass, which started in Barcelona on Friday 27 June. There were 150 participants who listened to a faculty of 12 internationally renowned experts...</description>
      <pubDate>Fri, 04 Jul 2008 11:26:30 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/66470150</guid>
      <dc:date>2008-07-04T11:26:30Z</dc:date>
    </item>
    <item>
      <title>Hepatocellular Cancer Therapy: New hepatocellular cancer therapy findings from Kagawa University,...</title>
      <link>http://www.newstin.com/tag/us/66466377</link>
      <description>Current study results from the report, 'A combination therapy of ethanol injection and radiofrequency ablation under general anesthesia for the treatment of hepatocellular carcinoma,' have been published. In this recently...</description>
      <pubDate>Fri, 04 Jul 2008 04:00:00 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/66466377</guid>
      <dc:date>2008-07-04T04:00:00Z</dc:date>
    </item>
    <item>
      <title>Life Sciences: Investigators at University of California, Comprehensive Cancer Center publish new...</title>
      <link>http://www.newstin.com/tag/us/66466360</link>
      <description>Fresh data on life sciences are presented in the report 'The epidermal growth factor receptor family: biology driving targeted therapeutics.' According to a study from the United States, "The epidermal growth factor family of...</description>
      <pubDate>Fri, 04 Jul 2008 04:00:00 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/66466360</guid>
      <dc:date>2008-07-04T04:00:00Z</dc:date>
    </item>
    <item>
      <title>Medicare Adds Third Recognized Source To Help Determine Coverage For Anti-Cancer Chemotherapy Drugs</title>
      <link>http://www.newstin.com/tag/us/66480009</link>
      <description>The Centers for Medicare &amp; Medicaid Services (CMS) announced additional updates to the information it uses in determining which drugs may be covered under Medicare Part B when used to treat patients undergoing cancer treatment...</description>
      <pubDate>Fri, 04 Jul 2008 12:18:21 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/66480009</guid>
      <dc:date>2008-07-04T12:18:21Z</dc:date>
    </item>
  </channel>
</rss>

